共 50 条
- [42] The use of novel promotility and prosecretory agents for the treatment of chronic idiopathic constipation and irritable bowel syndrome with constipation Advances in Therapy, 2009, 26 : 519 - 530
- [43] Mechanisms of Action of Current Pharmacologic Options for the Treatment of Chronic Idiopathic Constipation and Irritable Bowel Syndrome With Constipation AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (4S): : S6 - S13
- [46] Efficacy and Safety of Plecanatide in Patients With Chronic Idiopathic Constipation or Irritable Bowel Syndrome With Constipation: Intrinsic Factors Analyses From Four Studies AMERICAN JOURNAL OF GASTROENTEROLOGY, 2020, 115 : S243 - S243
- [50] SAFETY AND EFFICACY OF TEGASEROD THERAPY IN PATIENTS WITH IRRITABLE BOWEL SYNDROME OR CHRONIC CONSTIPATION JOURNAL OF POPULATION THERAPEUTICS AND CLINICAL PHARMACOLOGY, 2010, 17 (01): : E194 - E200